Elosity removes the friction that causes delays, rework, and uncertainty in clinical trials. Designed around real‑world operations, Elosity pairs configurable RTSM workflows with eloAITM intelligence and audit‑ready oversight, enabling sponsors and CROs to adapt faster, gain real‑time insight, and execute with confidence—without compromising governance.

RTSM shouldn’t be the rate‑limiting step. Elosity enables rapid study configuration, real‑time design previews, and streamlined workflows—so teams move from protocol to execution faster, without waiting on rigid builds or downstream rework.
Protocol amendments and evolving study designs are inevitable. Elosity supports controlled, version‑tracked updates with standardized requirements and clear change history—allowing teams to adapt confidently without interrupting live studies or introducing risk.
Elosity removes friction from RTSM data access. With eloAITM –powered conversational insight, teams can ask questions, surface trends, and act in real time—without waiting on static reports or technical dependencies.
Global supply introduces complexity across depots, sourcing strategies, and sites. Elosity simplifies trial supply management with intelligent workflows, flexible pooling, and centralized oversight—helping teams reduce waste, manage change, and keep supply aligned with enrollment.
Oversight is built in. Elosity delivers human‑readable audit trails, role‑based access, and field‑level traceability across RTSM workflows—supporting inspection readiness, compliance, and confident governance at scale.
Elosity integrates seamlessly with the broader clinical technology landscape. Pre‑built integrations, standardized data flows, and automation reduce friction between RTSM and connected systems—so execution stays aligned across teams, vendors, and platforms.
Elosity represents the fifth generation of Endpoint RTSM platforms, incorporating decades of lessons from global trials across therapeutic areas, geographies, and complexity levels.
Elosity enables rapid study configuration and mid-study updates—helping teams move from requirements to execution in as little as 2–6 weeks while maintaining full governance and compliance
Elosity represents the fifth generation of Endpoint RTSM platforms, incorporating decades of lessons from global trials across therapeutic areas, geographies, and complexity levels.
Endpoint’s leadership team brings more than 200 years of combined clinical trial and RTSM expertise, guiding platform strategy, delivery, and innovation.
Endpoint is dedicated exclusively to Randomization and Trial Supply Management, allowing Elosity to evolve with purpose as clinical trials become more complex and data-driven.
Every delay, workaround, or missing signal in a clinical trial has consequences for patients waiting on answers. Elosity R3 strengthens RTSM where it matters most—bringing real-time intelligence, adaptable trial execution, and audit-ready oversight together so trials stay on track, data remains trustworthy, and critical therapies reach patients without unnecessary friction.

R3 removes friction from RTSM data access by embedding intelligence directly into operational workflows. With eloAITM-powered insight, teams can move from questions to answers instantly without waiting on reports, exports, or technical support.
Key R3 Capabilities

Clinical trials evolve constantly. R3 strengthens Elosity’s ability to support change without disruption—simplifying how studies, sites, and supply are configured, updated, and maintained across the trial lifecycle.
Key R3 Capabilities

R3 strengthens governance across global trials—embedding transparency, traceability, and compliance directly into RTSM workflows rather than layering them on after the fact.
Key R3 Capabilities
As clinical trials grow more complex and patient expectations continue to rise, RTSM must evolve beyond static systems and siloed workflows. Elosity reflects a different approach—a modern RTSM platform designed to deliver clarity, intelligence, and oversight where clinical trial execution matters most.
Elosity is built around three outcomes modern trials demand: speed without shortcuts, quality without compromise, and agility without disruption. These principles shape every design decision—from how studies are configured to how change is managed and oversight scales—so RTSM supports confident trial execution even as complexity grows.

Clinical teams shouldn’t have to wait for answers—or rely on static reports—when decisions matter most. eloAITM removes friction from the RTSM data experience by embedding intelligence directly into Elosity workflows.
Teams move from questions to decisions instantly, with confidence in blinding, data integrity, and compliance. eloAITM is not a standalone tool or future roadmap. It’s an embedded, multi‑agent intelligence layer designed to support real‑world trial execution—across data insight, supply operations, and study change.

Clinical teams shouldn’t have to wait for answers. eloAITM delivers real-time, conversational insight directly within the Elosity RTSM platform, providing secure access to RTSM data across studies and operations. Teams move from questions to decisions instantly—without compromising blinding, data integrity, or regulatory compliance.
Instead of relying on static reports or manual exports, teams can explore clinical trial data in real time, surfacing trends, answering operational questions, and supporting faster decision-making across the study lifecycle.
Key Capabilities

Global trials introduce complexity across depots, central pharmacies, sourcing strategies, and regional distribution models. eloAITM brings intelligence directly into trial supply operations, helping teams anticipate demand, adapt sourcing strategies, and maintain full oversight from depot to patient.
By combining real-time operational insight with configurable supply workflows, teams can manage supply proactively—reducing waste, minimizing risk, and keeping inventory aligned with enrollment.
Key Capabilities

Protocol amendments and evolving study designs shouldn’t disrupt trial execution. eloAITM helps teams manage change with structure and confidence, supporting standardized requirements, controlled updates, and clear version traceability across the RTSM lifecycle.
Instead of introducing risk or rework, teams can implement updates faster while preserving validation, governance, and UAT readiness.
Key Capabilities
.webp)
RTSM shouldn’t be the rate‑limiting step. Elosity enables rapid study configuration, real‑time design previews, and streamlined workflows—so teams move from protocol to execution faster, without waiting on rigid builds or downstream rework.

Clinical teams shouldn’t have to wait for answers—or rely on static reports—when decisions matter most. eloAITM removes friction from the RTSM data experience by embedding intelligence directly into Elosity workflows.
Teams move from questions to decisions instantly, with confidence in blinding, data integrity, and compliance.eloAITM is not a standalone tool or future roadmap. It’s an embedded, multi‑agent intelligence layer designed to support real‑world trial execution—across data insight, supply operations, and study change.

Protocol amendments and evolving study designs are inevitable. Elosity supports controlled, version‑tracked updates with standardized requirements and clear change history—allowing teams to adapt confidently without interrupting live studies or introducing risk.

Clinical teams shouldn’t have to wait for answers. eloAITM delivers real-time, conversational insight directly within the Elosity RTSM platform, providing secure access to RTSM data across studies and operations. Teams move from questions to decisions instantly—without compromising blinding, data integrity, or regulatory compliance.
Instead of relying on static reports or manual exports, teams can explore clinical trial data in real time, surfacing trends, answering operational questions, and supporting faster decision-making across the study lifecycle.
Key Capabilities

Elosity removes friction from RTSM data access. With eloAI (AI is written in superscript)–powered conversational insight, teams can ask questions, surface trends, and act in real time—without waiting on static reports or technical dependencies.

Global trials introduce complexity across depots, central pharmacies, sourcing strategies, and regional distribution models. eloAITM brings intelligence directly into trial supply operations, helping teams anticipate demand, adapt sourcing strategies, and maintain full oversight from depot to patient.
By combining real-time operational insight with configurable supply workflows, teams can manage supply proactively—reducing waste, minimizing risk, and keeping inventory aligned with enrollment.
Key Capabilities

Global supply introduces complexity across depots, sourcing strategies, and sites. Elosity simplifies trial supply management with intelligent workflows, flexible pooling, and centralized oversight—helping teams reduce waste, manage change, and keep supply aligned with enrollment.

Protocol amendments and evolving study designs shouldn’t disrupt trial execution. eloAITM helps teams manage change with structure and confidence, supporting standardized requirements, controlled updates, and clear version traceability across the RTSM lifecycle.
Instead of introducing risk or rework, teams can implement updates faster while preserving validation, governance, and UAT readiness.
Key Capabilities
Hear from Endpoint leadership on how Elosity is redefining RTSM—turning complexity into clarity across data, supply, and study change to support modern clinical trials at scale.
Elosity is designed for the teams accountable for moving clinical trials forward—through complexity, change, and real‑world operational constraints. By removing friction across data, supply, and study change, Elosity enables confident decision‑making at every stage of the trial lifecycle.

Elosity helps sponsors move trials forward-without sacrificing quality, governance, or oversight

Elosity enables CROs to remain agile partners while managing operational complexity

Elosity keeps supply aligned with enrollment-without manual friction.

Elosity helps clinical operations teams adapt quickly-without slowing study progress.